This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2018 Sep 11;320(10):1031-1032.

doi: 10.1001/jama.2018.12194.

Diagnosis and Treatment of Clostridium difficile Infection

Arjun Gupta¹, Adam S Cifu², Sahil Khanna³

Affiliations

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
² Department of Internal Medicine, University of Chicago, Chicago, Illinois.
³ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

PMID: 30178042
DOI: 10.1001/jama.2018.12194

Diagnosis and Treatment of Clostridium difficile Infection

Arjun Gupta et al. JAMA. 2018.

. 2018 Sep 11;320(10):1031-1032.

doi: 10.1001/jama.2018.12194.

Authors

Arjun Gupta¹, Adam S Cifu², Sahil Khanna³

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
² Department of Internal Medicine, University of Chicago, Chicago, Illinois.
³ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

PMID: 30178042
DOI: 10.1001/jama.2018.12194

No abstract available

PubMed Disclaimer

Comment in

Treatment of Recurrent Clostridium difficile Infection.
Johnson S, Gerding DN. Johnson S, et al. JAMA. 2019 Feb 5;321(5):512-513. doi: 10.1001/jama.2018.18993. JAMA. 2019. PMID: 30721288 No abstract available.

Similar articles

Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence.
Zar FA. Zar FA. Ann Intern Med. 2016 Jul 19;165(2):JC4. doi: 10.7326/ACPJC-2016-165-2-004. Ann Intern Med. 2016. PMID: 27429316 No abstract available.
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
Hvas CL, Dahl Jørgensen SM, Jørgensen SP, Storgaard M, Lemming L, Hansen MM, Erikstrup C, Dahlerup JF. Hvas CL, et al. Gastroenterology. 2019 Apr;156(5):1324-1332.e3. doi: 10.1053/j.gastro.2018.12.019. Epub 2019 Jan 2. Gastroenterology. 2019. PMID: 30610862 Clinical Trial.
Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.
Rao K, Malani PN. Rao K, et al. JAMA. 2020 Apr 14;323(14):1403-1404. doi: 10.1001/jama.2019.3849. JAMA. 2020. PMID: 32150234 Review. No abstract available.
Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK; OPT-80-003 Clinical Study Group. Louie TJ, et al. N Engl J Med. 2011 Feb 3;364(5):422-31. doi: 10.1056/NEJMoa0910812. N Engl J Med. 2011. PMID: 21288078 Clinical Trial.
[Individualized treatment strategies for Clostridium difficile infections].
Solbach P, Dersch P, Bachmann O. Solbach P, et al. Internist (Berl). 2017 Jul;58(7):675-681. doi: 10.1007/s00108-017-0268-2. Internist (Berl). 2017. PMID: 28589214 Review. German.

See all similar articles

Cited by

Advances in Therapeutic Strategies for the Management of Clostridioides difficile Infection.
Vitiello A, Sabbatucci M, Zovi A, Salzano A, Ponzo A, Boccellino M. Vitiello A, et al. J Clin Med. 2024 Feb 26;13(5):1331. doi: 10.3390/jcm13051331. J Clin Med. 2024. PMID: 38592194 Free PMC article. Review.
Clostridioides difficile Infection: Landscape and Microbiome Therapeutics.
Gawey BJ, Khanna S. Gawey BJ, et al. Gastroenterol Hepatol (N Y). 2023 Jun;19(6):319-328. Gastroenterol Hepatol (N Y). 2023. PMID: 37706187 Free PMC article.
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.
Berry P, Khanna S. Berry P, et al. BioDrugs. 2023 Nov;37(6):757-773. doi: 10.1007/s40259-023-00617-2. Epub 2023 Jul 26. BioDrugs. 2023. PMID: 37493938 Review.
Host Immunity and Immunization Strategies for Clostridioides difficile Infection.
Naz F, Petri WA. Naz F, et al. Clin Microbiol Rev. 2023 Jun 21;36(2):e0015722. doi: 10.1128/cmr.00157-22. Epub 2023 May 10. Clin Microbiol Rev. 2023. PMID: 37162338 Free PMC article. Review.
The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation.
Bachour SP, Dalal R, Allegretti JR. Bachour SP, et al. Therap Adv Gastroenterol. 2023 Apr 17;16:17562848231165581. doi: 10.1177/17562848231165581. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37091531 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information